Montana State University

Aging brain to be focus of April 20 lecture at MSU

April 9, 2009 -- From MSU News Service


Stuart Lipton will speak about new drug treatments and the future of stem cells for the aging brain during an April 20 lecture at MSU.   High-Res Available

Subscribe to MSU Newsletters


Bobcat Bulletin is a weekly e-newsletter designed to bring the most recent and relevant news about Montana State University directly to friends and neighbors via email. Visit Bobcat Bulletin.

MSU Today e-mail brings you news and events on campus thrice weekly during the academic year. Visit the MSU Today calendar.

MSU News Service
Tel: (406) 994-4571
msunews@montana.edu
BOZEMAN -- New drug treatments and the future of stem cells for the aging brain will be the topic of a free public lecture to be given Monday, April 20, at Montana State University.

Stuart Lipton, a physician and researcher in the field of neuroscience and its diagnostic and therapeutic consequences, will speak at 5 p.m. in the Procrastinator Theater in the Student Union Building. A reception will follow in the Leigh Lounge.

Lipton is program director and professor at the Del E. Webb Neuroscience, Aging and Stem Cell Research Center in La Jolla, Calif. His lab developed the first glutamate receptor/channel antagonist drug (Memantine) to be clinically approved for dementia. His lab also studies the cloning of a gene that programs embryonic stem cells to become nerve cells in the brain. These studies have led to the development of the first neuroprotective drugs to be administered successfully to humans to combat various neurodegenerative and vascular diseases of the brain.

In 2004, Lipton was the co-recipient of the prestigious Ernst Jung Prize for medicine. This international award, endowed by German industrialist Ernst Jung, recognizes discoveries that have a major impact on experimental medicine.

Lipton's lecture is presented by the Kopriva Science Seminar Series, which is funded through an endowment created by Phil Kopriva, a 1957 microbiology graduate from MSU. Kopriva, who died in 2002, also created an endowment to fund the Kopriva Graduate Fellowship Program which provides support and opportunities for graduate students in MSU's College of Letters and Science, particularly in the biomedical sciences. The series will feature four seminars annually, with talks given by MSU graduate students, faculty members and guest speakers.

For more information, visit http://www.montana.edu/lettersandscience/kopriva.html

Evelyn Boswell, (406) 994-5135 or evelynb@montana.edu